We are thrilled to announce that Evotec will be 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗼𝘂𝗿 𝗹𝗮𝘁𝗲𝘀𝘁 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝙞𝙣 𝙫𝙞𝙫𝙤 𝗺𝗼𝗱𝗲𝗹𝘀 at the #AACR25 conference! Our poster, titled "Humanized Mice Models for Immune-Oncology Studies", showcases the innovative capabilities of our huPBMC and huCD34+ mice models. These models are pivotal for evaluating new therapeutic agents, providing a more relevant immune context 𝘪𝘯 𝘷𝘪𝘷𝘰. 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: • HuPBMC Mice: Exclusively T-cell lineage, resistant to GvHD, ideal for testing therapeutics requiring effector T-cell function. • HuCD34+ Mice: Multilineage immune population, applicable for assessing immunomodulatory agents and immune checkpoint therapies. Join us at AACR 2025, 𝗯𝗼𝗼𝘁𝗵 # 𝟮𝟱𝟰𝟮 to explore how our humanized mice models can accelerate your research and development in immune-oncology. Don't miss the opportunity to connect with our experts and learn more about our cutting-edge capabilities! 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗼𝗿 𝗯𝗼𝗼𝗸 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴- https://hubs.ly/Q03fVWfS0 #AACR #invivoModels #Oncology #ImmunoOncology
